The results demonstrate that ISL inhibits the proliferation and invasion of CRC cells in vitro, with the potential mechanism involving downregulation of the PI3K/AKT pathway and suppression of FGFT4-dependent lipid metabolism. The gene discussed is AKT1; the disease is colorectal carcinoma.